The Janus Corner

groupview

Abstract
Pharmacognosy Communications,2017,7,4,174-175.
Published:November 2017
Type:The Janus Corner

The Janus Corner

Ian E Cock1,2*, Esther SG Cock3

1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

2Environmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

3Medical Oncology Dept, Mater Hospital, Raymond Terrace, South Brisbane, 4101, AUSTRALIA.

Abstract:

Plant species of the genus Taraxacum (commonly known as dandelion) have a long history of use in the treatment of a myriad of medical conditions including uses for the eradication of pathogenic disease, the treatment of liver complaints and as a diuretic.1 A recent study from researchers at the University of Windsor in Ontario, Canada has reported that dandelion root extracts are also effective in fighting cancer.2-6 Of particular note, dandelion root extracts induced apoptosis in a chronic myeloid leukaemia cell line.5 That finding was noteworthy as the cell line tested was particularly aggressive and is resistant to many other cancer chemotherapy agents. The research team have also trialled the extract on other leukaemia cell lines,2 as well as melanoma3 and pancreatic cancer4 cells with similar results. Whilst this finding is promising for people with these diseases, the authors of the study have urged caution. Bioactive compounds within the dandelion root may interfere with conventional cancer chemotherapies. It is therefore important that patients do not mix the natural remedy with conventional chemotherapies without close medical supervision and that patients notify their medical practitioners if they intend to use dandelion root formulations for these purposes....Read more

Cite This Article

Vancouver Style :: Cock IE, Cock ESG. The Janus Corner. Pharmacognosy Communications. 2017;7(4):174-175.  (338.06 KB)
MLA Style: Cock IE, Cock ESG. The Janus Corner. Pharmacognosy Communications. 2017;7(4):174-175.  (338.06 KB)
CSE Style: Cock IE, Cock ESG. The Janus Corner. Pharmacognosy Communications. 2017;7(4):174-175.  (338.06 KB)
APA Style: Cock IE, Cock ESG. The Janus Corner. Pharmacognosy Communications. 2017;7(4):174-175.  (338.06 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.